Cargando…
Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
BACKGROUND: There are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening. DISCUSSION: While all screening programs aim to detect disease early in order to improve the length and/or quality of life for t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548714/ https://www.ncbi.nlm.nih.gov/pubmed/23272939 http://dx.doi.org/10.1186/1471-230X-12-183 |
_version_ | 1782256353528512512 |
---|---|
author | Flitcroft, Kathy L Irwig, Les M Carter, Stacy M Salkeld, Glenn P Gillespie, James A |
author_facet | Flitcroft, Kathy L Irwig, Les M Carter, Stacy M Salkeld, Glenn P Gillespie, James A |
author_sort | Flitcroft, Kathy L |
collection | PubMed |
description | BACKGROUND: There are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening. DISCUSSION: While all screening programs aim to detect disease early in order to improve the length and/or quality of life for the individual, some organizations and individuals prefer screening tests that offer the opportunity for cancer prevention. Others favor maximizing participation or the opportunity for shared decision-making, including discussion of information on test quality and availability. We propose three additional objectives for screening: minimizing harms, optimizing economic efficiency and maximizing equity of access to screening. SUMMARY: Applying these objectives to colorectal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy, as it satisfies all three of these important objectives. |
format | Online Article Text |
id | pubmed-3548714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35487142013-02-04 Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option Flitcroft, Kathy L Irwig, Les M Carter, Stacy M Salkeld, Glenn P Gillespie, James A BMC Gastroenterol Debate BACKGROUND: There are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening. DISCUSSION: While all screening programs aim to detect disease early in order to improve the length and/or quality of life for the individual, some organizations and individuals prefer screening tests that offer the opportunity for cancer prevention. Others favor maximizing participation or the opportunity for shared decision-making, including discussion of information on test quality and availability. We propose three additional objectives for screening: minimizing harms, optimizing economic efficiency and maximizing equity of access to screening. SUMMARY: Applying these objectives to colorectal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy, as it satisfies all three of these important objectives. BioMed Central 2012-12-29 /pmc/articles/PMC3548714/ /pubmed/23272939 http://dx.doi.org/10.1186/1471-230X-12-183 Text en Copyright ©2012 Flitcroft et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Debate Flitcroft, Kathy L Irwig, Les M Carter, Stacy M Salkeld, Glenn P Gillespie, James A Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option |
title | Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option |
title_full | Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option |
title_fullStr | Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option |
title_full_unstemmed | Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option |
title_short | Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option |
title_sort | colorectal cancer screening: why immunochemical fecal occult blood tests may be the best option |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548714/ https://www.ncbi.nlm.nih.gov/pubmed/23272939 http://dx.doi.org/10.1186/1471-230X-12-183 |
work_keys_str_mv | AT flitcroftkathyl colorectalcancerscreeningwhyimmunochemicalfecaloccultbloodtestsmaybethebestoption AT irwiglesm colorectalcancerscreeningwhyimmunochemicalfecaloccultbloodtestsmaybethebestoption AT carterstacym colorectalcancerscreeningwhyimmunochemicalfecaloccultbloodtestsmaybethebestoption AT salkeldglennp colorectalcancerscreeningwhyimmunochemicalfecaloccultbloodtestsmaybethebestoption AT gillespiejamesa colorectalcancerscreeningwhyimmunochemicalfecaloccultbloodtestsmaybethebestoption |